
    
      This is a randomized, open-labelled, multicenter pilot study using an individually randomized
      stepped wedge design over a 24 weeks period to evaluate topical application of 1 mg/mL
      sirolimus solution, 0.5 mL to 1 mL according to the size of the lesion, once daily, on
      lingual microcystic lymphatic malformation that do not require systemic treatment, the
      experimental intervention versus usual care (no treatment), the control condition.

      In this design, subjects are included in a cohort where at a randomized time (W0, W4, W8 or
      W12), they switch from an observational period to the interventional period.

      All subjects will be followed for 24 weeks
    
  